JP3179108B2 - 胃潰瘍及び十二指腸潰瘍を治療及び阻止する方法 - Google Patents

胃潰瘍及び十二指腸潰瘍を治療及び阻止する方法

Info

Publication number
JP3179108B2
JP3179108B2 JP52295595A JP52295595A JP3179108B2 JP 3179108 B2 JP3179108 B2 JP 3179108B2 JP 52295595 A JP52295595 A JP 52295595A JP 52295595 A JP52295595 A JP 52295595A JP 3179108 B2 JP3179108 B2 JP 3179108B2
Authority
JP
Japan
Prior art keywords
oligosaccharide
stomach
duodenum
mammal
pylori
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP52295595A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09509931A (ja
Inventor
エー． ゾプフ，デイヴィッド
エム． サイモン，ポール
ロース，ステフェン
エドワード ジェイ． マックガイアー
エイチ． ランジャー，デニス
Original Assignee
ネオーズ テクノロジーズ，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ネオーズ テクノロジーズ，インコーポレーテッド filed Critical ネオーズ テクノロジーズ，インコーポレーテッド
Publication of JPH09509931A publication Critical patent/JPH09509931A/ja
Application granted granted Critical
Publication of JP3179108B2 publication Critical patent/JP3179108B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP52295595A 1994-03-02 1995-03-02 胃潰瘍及び十二指腸潰瘍を治療及び阻止する方法 Expired - Fee Related JP3179108B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20451594A 1994-03-02 1994-03-02
US204,515 1994-03-02
PCT/US1995/002388 WO1995023605A1 (fr) 1994-03-02 1995-03-02 Procede de traitement et d'inhibition des ulceres gastriques et duodenaux

Publications (2)

Publication Number Publication Date
JPH09509931A JPH09509931A (ja) 1997-10-07
JP3179108B2 true JP3179108B2 (ja) 2001-06-25

Family

ID=22758224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52295595A Expired - Fee Related JP3179108B2 (ja) 1994-03-02 1995-03-02 胃潰瘍及び十二指腸潰瘍を治療及び阻止する方法

Country Status (5)

Country Link
EP (1) EP0749314A4 (fr)
JP (1) JP3179108B2 (fr)
AU (1) AU709149B2 (fr)
CA (1) CA2183329A1 (fr)
WO (1) WO1995023605A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
KR20000010732A (ko) * 1996-05-03 2000-02-25 스티븐 로쓰 시알릴올리고당의 비스무트염 및 이를 사용한위궤양 및 십이지장궤양 치료 및 억제 방법
US8003782B1 (en) 1999-02-01 2011-08-23 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
SE9901007D0 (sv) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
NL2007931C2 (en) * 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
WO2020060260A1 (fr) * 2018-09-20 2020-03-26 가톨릭대학교 산학협력단 Composite polymère pour la reconnaissance de l'helicobacter pylori et composition pour la thérapie photodynamique la comprenant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464687B (sv) * 1987-11-10 1991-06-03 Biocarb Ab Foerfarande foer framstaellning av en gelprodukt
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JPH0436294A (ja) * 1990-06-01 1992-02-06 Snow Brand Milk Prod Co Ltd 牛乳由来の新規なガングリオシド及びその製造法
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
US5254676A (en) * 1991-11-22 1993-10-19 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
EP0630251A1 (fr) * 1992-03-19 1994-12-28 University Of British Columbia Procede et composition permettant de supprimer les effets secondaires de medicaments anti-inflammatoires
WO1993023055A1 (fr) * 1992-05-15 1993-11-25 The University Of British Columbia Glucosamine d'acetyle-n en tant qu'agent gastroprotecteur
AU4993893A (en) * 1992-07-31 1994-03-03 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers

Also Published As

Publication number Publication date
CA2183329A1 (fr) 1995-09-08
AU1932395A (en) 1995-09-18
WO1995023605A1 (fr) 1995-09-08
JPH09509931A (ja) 1997-10-07
EP0749314A1 (fr) 1996-12-27
EP0749314A4 (fr) 2002-09-18
AU709149B2 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
US5514660A (en) Method for treating and inhibiting gastric and duodenal ulcers
Vishwanath et al. Tracheobronchial mucin receptor for Pseudomonas aeruginosa: predominance of amino sugars in binding sites
KR19990022658A (ko) 올리고사카라이드 화합물에 의한 박테리아 저해물질
US7858595B2 (en) Anti-infectious carbohydrates
JP2006506329A5 (fr)
JP3179108B2 (ja) 胃潰瘍及び十二指腸潰瘍を治療及び阻止する方法
WO1994003184A1 (fr) Compositions destinees a traiter et inhiber les ulceres gastriques et duodenaux
JP2003517015A (ja) ヘリコバクターピロリ結合性新規物質およびその用途
JP2006511497A (ja) ヘリコバクターピロリに対する高親和性レセプターおよびその用途
JP6612346B2 (ja) 感染症の予防および／または治療のための方法および試薬
US6242424B1 (en) Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives
JP2001505208A (ja) 糖脂質擬態とその利用方法
EP1663258A2 (fr) Traitement au moyen d'oligo-beta-(1,3)- glucanes et medicament utilises dans le cadre de ce traitement
AU710576B2 (en) Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
US20050220819A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
WO1998026662A1 (fr) Composes et methodes pour traiter et prevenir les maladies bacteriennes et virales
US7517851B2 (en) Chlamydia oligosaccharides
PT1357917E (pt) Utilização de hidratos de carbono para eliminar infecções intestinais em animais
MXPA98009158A (en) Salt of bismuto de sialiloligosacarido and a metodopara treat and inhibit gastric and duodenal ulceras with the mi
JP2003535965A5 (fr)
JPH1045602A (ja) ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
KR20010022739A (ko) 헬리코박터 필로리의 정착 저해제
JP2002308784A (ja) ヘリコバクター・ピロリ除菌剤
MXPA98001875A (en) Salts of bismuto of antibiotics of the lamoenomycin group, procedure for its preparation, its use and medicines containing such sa
JP2017057174A (ja) 免疫グロブリンａ分泌促進剤

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees